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doi:10.1016/j.ejvs.2011.02.016Abstract Objectives: (i) Prevalence of stroke in neurologically symptomatic/asymptomatic
patients with unilateral/bilateral carotid disease (including occlusion) undergoing cardiac
surgery without prophylactic carotid endarterectomy (CEA) or carotid stenting (CAS). (ii) Prev-
alence of stroke in asymptomatic patients with unilateral/bilateral carotid disease (excluding
occlusion) who underwent isolated cardiac surgery. (iii) Prevalence of stroke in the hemisphere
ipsilateral to a non-operated asymptomatic stenosis in patients with severe bilateral carotid
disease undergoing a synchronous unilateral CEA þ cardiac procedure.
Methods: Systematic Review and meta-analysis.
Results: Cardiac surgery patients with a symptomatic/asymptomatic 50e99% stenosis or occlu-
sion incurred a 7.4% stroke risk (95%CI 4.8e9.9), increasing to 9.1% (95%CI 4.8e16) in those with
80e99% stenoses or occlusion. After excluding patientswith a history of stroke/TIA and thosewith
isolated/bilateral occlusions, the stroke risk fell to 3.8% (95%CI 2.0e4.8) in patients with asymp-
tomatic 50e99%stenosesand2.0% in thosewith70e99%stenoses (95%CI 1.0e5.7).Theprevalence
of ipsilateral stroke in patients with a unilateral, asymptomatic 50e99% stenosis was 2.0%
(1.0e3.8), while the risk of any stroke was only 2.9% (2%e5.7%). These risks did not increase with
stenosis severity (70e99%, 80e99%). Patients with bilateral, asymptomatic 50e99% stenoses or
a 50e99% stenosisþ contralateral occlusion incurred a 6.5% stroke risk following cardiac surgery,
while the risk of death/stroke was 9.1% (3.8%e20.6%). Patients with bilateral 80e99% stenoses
undergoing a unilateral synchronous cardiac/carotid revascularisation incurred a 5.7% risk of
stroke in the hemisphere ipsilateral to the non-operated, contralateral stenosis.education questions on this paper, please go to www.vasculareducation.com and click on ‘CME’
gery Group, Division of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Infirmary,
2523252; fax: þ44 116 2523179.
.nhs.uk (A.R. Naylor).
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608 A.R. Naylor, M.J. BownConclusions: There is no compelling evidence supporting a role for prophylactic CEA/CAS in
cardiac surgery patients with unilateral asymptomatic carotid disease. Prophylactic CEA/CAS
might still be considered in patientswith severe, bilateral asymptomatic carotid disease, but such
a strategy would only benefit 1e2% of all cardiac surgery patients.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Stroke complicates 2% of all cardiac surgery procedures and
remains an important cause of mortality and permanent
neurological disability1 Accordingly, a number of strategies
have been developed for minimising peri-operative stroke;
including; avoiding (correcting) low cardiac output states,
prompt treatment of arrhythmias, minimising aortic
dissection and cannulation, off-pump bypass, membrane
oxygenators, arterial line filters, avoidance of intra-oper-
ative hyperglycaemia, optimisation of cerebral oxygenation
and, of course, prophylactic carotid endarterectomy (CEA)
or carotid artery stenting (CAS) in patients with significant
carotid artery disease.
The most controversial of these strategies has been
whether CEA or CAS significantly reduces the risk of stroke
after cardiac surgery, particularly in patients with asymp-
tomatic carotid disease. To some observers, the evidence
already does support a role for prophylactic CEA or CAS2,3 and
these physicians can cite American Heart Association (AHA)
guidelines4 should anyone challenge their practice. By
contrast, others have reviewed exactly the same data and
concluded that carotid disease was little more than a surro-
gate marker for other (more important) stroke aetiologies;
especially atheroembolism from a diseased aortic arch.5
The rationale for performing prophylactic CEA/CAS is
fundamentally dependent upon; (i) carotid disease being an
important cause of stroke after cardiac surgery and that (ii)
the risks associated with staged or synchronous CEA/CAS do
not exceed the risk of stroke should the cardiac procedure
be performed in isolation. If either of these assumptions
(especially the former) is flawed, the case for prophylactic
intervention (of any sort) becomes vulnerable to challenge.
The prevention of long-term stroke cannot be used as a
justification for offering prophylactic CEA or CAS prior to
a cardiac surgery procedure.
A number of studies (including several older systematic
reviews) have suggested that there is a causal relationship
between asymptomatic carotid disease and stroke after
cardiac surgery and these have proved pivotal in developing
AHA guidelines supporting prophylactic CEA or CAS.4
However, a critical review of the evidence suggests that
much of the data supporting a role for prophylactic inter-
vention may be open to challenge. Examples include; (i) the
effect of including patients with isolated or bilateral carotid
occlusions (which cannot be treated by CEA/CAS) within
a cohort of patients with stenosis in order to artificially
increase the natural history risk of stroke following isolated
cardiac procedures6e15 (a practice usually disguised by
reporting outcomes in patients with ‘>50% stenoses’ or
‘>70% stenoses’), (ii) a tendency to cite older natural history
studies (which tend to show a positive association between
carotid disease and stroke), to the exclusion of other morerecent natural history studies which have reported very low
risks of stroke16e19 and (iii) recent awareness that the risk of
stroke in the hemisphere ipsilateral to a non-operated,
contralateral severe stenosis in patients with bilateral,
severe carotid disease undergoing a unilateral synchronous
carotid and cardiac procedure may be quite low.20 If carotid
disease really was such an important cause of stroke after
cardiac surgery, one would normally have expected to find
a much higher risk of stroke in this subgroup of patients.
The three systematic reviews in this paper represent the
most comprehensive analysis of all of the published data
ever undertaken regarding the relationship between
asymptomatic carotid disease and stroke following cardiac
surgery.
Materials and Methods
Three systematic reviews and meta-analyses were under-
taken. In the first, a ‘traditional’ literature review was
performed to determine rates of stroke and death in
patients undergoing cardiac surgery in the presence of an
unoperated ‘>50% carotid stenosis’ (i.e. any combination of
symptomatic/asymptomatic patients with unilateral/bilat-
eral 50e99% stenoses or occlusion). The second systematic
review was undertaken to determine the 30-day risks
of ipsilateral stroke, any stroke, death, death/ipsilateral
stroke and death/any stroke in neurologically asymptomatic
patients with unilateral or bilateral significant carotid
stenoses (i.e. excluding patients with isolated or bilateral
occlusions) who then underwent isolated cardiac surgery
without synchronous CEA or CAS. The third systematic
review was undertaken in patients undergoing a unilateral,
synchronous carotid/cardiac procedure in the presence of
severe bilateral carotid disease in order to determine the
30-day risk of stroke in the hemisphere ipsilateral to the
non-operated, contralateral carotid stenosis or occlusion.
Studies were identified by manual journal reviews (Euro-
pean Journal of Vascular and Endovascular Surgery, Journal
of Vascular Surgery, Annals of Vascular Surgery, Stroke,
Annals of Thoracic Surgery, Journal of Thoracic and
Cardiothoracic Surgery, Journal of Cardiovascular Surgery),
cross-referencing and an electronic PUBMED search using the
advanced search option. A number of combinations of search
terms were used that included one of ‘carotid endarterec-
tomy’, ‘carotid surgery’, ‘carotid stenosis’ ‘coronary
surgery’, or ‘bypass surgery’, in combination with one of
‘stroke’, carotid’ or ‘cardiac’ as appropriate. In each
systematic review, the term ‘cardiac surgery’ referred to any
patient undergoing coronary artery bypass surgery (CABG),
valve replacement or any combination of the two. The vast
majority of patients, however, had undergone CABG.
One hundred and sixty-six studies were identified
following a comprehensive literature review for potential
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this paper.7e172 In the first systematic review, 26 stud-
ies7,9,11e14,16e19,21e29,31e34,36,38,40 reported rates of stroke,
death and death/stroke in cardiac surgery patients who had
a symptomatic or asymptomatic (unilateral or bilateral)
carotid artery stenosis (>50%) and/or isolated/bilateral
occlusion in whom CEA and CAS was not performed prior to
the cardiac surgical procedure.
Thirty-six eligible studies7e19,21e44 were identified for
inclusion in the second systematic review, of which
thirteen16e19,21e30 fulfilled the specified inclusion criteria
(stenosis severity documented, outcomes for unilateral/
bilateral disease specified separately, separate data for
symptomatic and neurologically asymptomatic patients,
separate data for patients with stenosis or occlusion).
Twenty-three studies were excluded;7e15,31e45 nine
because they did not differentiate between patients with
stenosis and occlusion;7e15 six combined data for symp-
tomatic and neurologically asymptomatic patients,31e36
four did not differentiate between stenosis and occlusion
and also combined data for symptomatic and neurologi-
cally asymptomatic patients,37e40 while five were
excluded for miscellaneous reasons including; data for
patients undergoing peripheral vascular and coronary
procedures were not detailed separately.41 In Hertzer’s
series, some patients underwent CEA in the early post-
operative period following their isolated cardiac proce-
dure.42 In Nakamura’s study, outcomes were combined for
patients with intra- and extracranial occlusive disease,43
no differentiation was made between unilateral and
bilateral disease in Vingerhoets study,44 while one study
only included a single patient with a significant carotid
stenosis.45
In the third systematic review, 141 studies
2,5,10,14,15,18,20e22,29,38,77e172 reported stroke rates following
synchronous unilateral carotid/cardiac procedures and
were eligible for inclusion; of which 3520e22,30,37,46e76 ful-
filled the pre-specified inclusion criteria (rates of contra-
lateral stroke documented, extent of contralateral carotid
disease documented, outcomes reported separately for
contralateral stenosis and occlusion, no bilateral CEAs, >5
cases with bilateral severe disease reported). One hundred
and five studies2,10,14,15,18,27e29,37,41,76e172 were excluded
following a review of the data; 63 provided no data
regarding rates of contralateral stroke,2,10,14,15,26e28,77e135
while eleven did report contralateral stroke rates sepa-
rately, but did not then correlate these strokes with patterns
of contralateral carotid disease.135e145 Four provided rates
of contralateral stroke, but did not discriminate between
contralateral occlusion and stenosis.53,146e148 Finally, 28
studieswere excluded formiscellaneous reasons; 11 because
the report contained fewer than 5 caseswith severe bilateral
disease,29,38,149e157 six series performed staged or synchro-
nous bilateral CEAs,158e162 three studies did not discriminate
outcomes for staged and synchronous procedures,163e165
four provided virtually no data on patients undergoing
synchronous surgery,18,166e168 Reul169 and Vermeulen170 did
not separate outcomes for synchronous CEA/CABG from
those undergoing other synchronous interventions (e.g.
brachiocephalic reconstruction, peripheral arterial recon-
struction), while Wareing’s series included duplicated
data.171Statistical analyses
Meta-analyses were performed for the three primary
outcome measures of stroke, death and combined death/
stroke. All data extracted consisted of rates in the form of
proportions. In accordance with statistical practice, zero
proportions were entered into meta-analyses by adding 0.5
to the numerator and 1.0 to the denominator. This does,
however, increase the possibility of artificially increasing
the combined estimate when analysing studies containing
many zero percent risks and this should be considered when
reviewing the results of the meta-analyses, especially
systematic review #3. Proportions were converted to a log
odds scale for subsequent meta-analysis. Meta-analyses
were performed using random effects models in all cases
since it was perceived that the outcome measures being
explored were unlikely to be fixed across all populations
and there was evidence of heterogeneity from the exami-
nation of the primary data from the studies being
combined. The presence of between-studies heterogeneity
was determined using the standard Chi-squared test.172
Meta-analyses were performed using Review Manager
Version 5 with a generic inverse variance model. All results
were converted back to percentages for ease of interpre-
tation. Formal sensitivity analyses were not performed due
to a lack of robust study quality measures upon which to
base such analyses and similarly, publication bias assess-
ments were not attempted due to the relatively low
number of studies in each meta-analysis.
Results
Systematic review #1
What was the prevalence of peri-operative stroke in
neurologically symptomatic/asymptomatic patients with
unilateral or bilateral carotid disease (including any
occlusion) who underwent isolated cardiac surgery
without prophylactic CEA or CAS?
Most systematic reviews do not discriminate between
stenosis/occlusion, bilateral/unilateral disease and (most
importantly) whether the cardiac surgery patient was
neurologically asymptomatic or symptomatic when deter-
mining whether patients with ‘carotid disease’ face
a higher risk of stroke following isolated cardiac surgery.
Accordingly, and in order to specifically allow comparison
with the results of the second systematic review in exclu-
sively asymptomatic patients, Table 1 details the preva-
lence of stroke and death in 26 published series comprising
2531 patients with a’ >50% stenosis or occlusion’ who
underwent isolated cardiac surgery. A meta-analysis
showed that the prevalence of stroke within 30 days of
undergoing an isolated cardiac surgery procedure in the
presence of an unoperated ‘>50% stenosis’ was 7.4% (95%CI
4.8e9.9), while the prevalence of death within 30 days was
7.4% (4.8%e10.7%) and the prevalence of death/stroke was
8.3% (95%CI 3.8e13.8).
A further meta-analysis was undertaken on data derived
from the constituent studies in Table 1, after stratifying for
whether patients had a ‘>70% stenosis’ or a ‘>80%
stenosis’. Ten studies (Table 2) reported outcomes in 654
Table 1 30-day stroke, death and stroke/death following cardiac surgery in patients with ‘>50%’ stenosis who did not undergo
prophylactic CEA/CAS.a
Author Year n Z Stroke Death Death/stroke
Turnipseed36 1980 20 2 10.0%
Barnes9 1981 40 3 7.5% 4 10.0% 7 17.5%
Breslau11 1981 18 0 0.0%
Ivey29 1984 19 3 15.8%
Brener22 1987 96 9 9.4% 14 14.6%
Schulz27 1988 50 0 0.0% 0 0.0% 0 0.0%
Faggioli14 1990 28 4 14.3% 2 7.1% 6 21.4%
Schwartz28 1995 130 5 3.8%
D’Agostino23 1996 229 17 7.4%
Mickleborough26 1996 33 4 12.1% 0 0.0% 4 12.1%
Dashe32 1997 79 10 12.7%
Hines34 1998 15 4 26.7% 1 6.7% 426.7%
Ali21 1998 46 0 0.0% 0 0.0% 0 0.0%
Safa19 1999 94 1 1.1% 0 0.0% 1 1.1%
Gott33 1999 162 27 16.7%
Birincioglu31 1999 70 5 7.1%
Hirotani38 2000 62 5 8.1%
Gaudino24 2001 73 1 1.4% 1 1.4% 2 2.8%
Ascher7 2001 297 13 4.4% 30 10.1%
Dworshiak13 2003 19 1 5.3% 3 15.8% 4 21.1%
Durand12 2004 106 8 7.5%
Ghosh17 2005 50 0 0.0% 2 4.0% 2 4.0%
Schoof40 2007 527 13 2.5%
Manabe25 2008 42 0 0.0% 0 0.0% 0 0.0%
Li18 2009 165 9 5.5%
Baiou16 2009 61 0 0.0% 3 4.9% 3 4.9%
Combined estimate (95%CI): 7.4% (4.8%e9.9%) 7.4% (4.8%e10.7%) 8.3% (3.8%e13.8%)
Heterogeneity: Tau2 Z 0.42; Chi2 Z 79.89,
df Z 25 (P < 0.00001);
I2 Z 69%
Tau2 Z 0.28; Chi2 Z 25.15,
df Z 13 (P Z 0.02);
I2 Z 48%
Tau2 Z 0.83; Chi2 Z 36.49,
df Z 12 (P Z 0.0003);
I2 Z 67%
Test for overall
effect:
Z Z 14.93 (P < 0.00001) Z Z 11.00 (P < 0.00001) Z Z 7.49 (P < 0.00001)
a Inclusion criteria: Meta-analysis included all neurologically symptomatic or asymptomatic patients with unilateral or bilateral
50e99% stenoses and/or unilateral or bilateral carotid occlusions who underwent their cardiac surgery procedure without prophylactic
CEA or CAS.
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isolated cardiac procedure. The prevalence of stroke,
death and death/stroke was 7.4% (95%CI 4.8e12.3), 4.8%
(2.0e8.3) and 6.5% (95%CI 2.9e15.3) respectively.
Seven studies (Table 3) reported outcomes following
isolated cardiac surgery in 488 neurologically symptomatic
or asymptomatic patients with an 80e99% stenosis or
occlusion (irrespective of whether this was unilateral or
bilateral). In this cohort of patients, the prevalence of
stroke was 9.1% (95%CI 4.8e16). There was insufficient data
to perform a meta-analysis for death or death/stroke in this
subgroup of patients.
In a previous systematic review and meta-analysis, the
prevalence of stroke in cardiac surgery patients with no
evidence of significant carotid disease (i.e. normal carotid
arteries or 0e49% stenoses) was 1.8% (95%CI 1.4e2.2).1
Accordingly, the main finding from systematic review #1
was that neurologically asymptomatic or symptomatic
patients undergoing isolated cardiac surgery in the pres-
ence of an untreated carotid stenosis or occlusion faced an
increased risk of procedural stroke ranging from 7.4% inpatients with 50e99% stenosis or occlusion to 9.1% (80e99%
stenosis or occlusion).Systematic review #2
What was the prevalence of peri-operative stroke in
neurologically asymptomatic patients with unilateral or
bilateral carotid disease (excluding isolated or bilateral
occlusion) who then underwent cardiac surgery without
prophylactic CEA or CAS?
The data presented in systematic review #1 are typical of
the style of presentation in most historical systematic
reviews that report a causal relationship between carotid
disease and stroke after cardiac surgery. These data are,
however, methodologically flawed because they combine
outcomes from symptomatic and asymptomatic patients,
those with unilateral and bilateral carotid disease and
patients with isolated/bilateral carotid occlusion (which
are untreatable and known to be associated with an
increased risk of procedural stroke1). The vast majority of
Table 2 30-day rates of stroke, death and stroke/death after cardiac surgery in neurologically symptomatic or asymptomatic
patients who had ‘>70% stenosis’ (including occlusion) who did not undergo prophylactic CEA/CAS.a
Author Year n Z Stroke Death Death/stroke
Faggioli14 1990 28 4 14.3% 2 7.1% 6 21.4%
Mickleborough26 1996 33 4 12.1% 0 0.0% 4 12.1%
Dashe32 1997 31 5 16.1%
Safa19 1999 94 1 1.1% 0 0.0% 1 1.1%
Hirotani38 2000 44 4 9.1%
Durand12 2004 106 8 7.5%
Ghosh17 2005 50 0 0.0% 2 4.0% 2 4.0%
Manabe25 2008 42 0 0.0% 0 0.0% 0 0.0%
Li18 2009 165 9 5.5%
Baiou16 2009 61 0 0.0% 3 4.9% 3 4.9%
Combined estimate
(95%CI):
7.4% (4.8%e12.3%) 4.8% (2%e8.3%) 6.5% (2.9%e15.3%)
Heterogeneity: Tau2 Z 0.35;
Chi2 Z 19.50, df Z 9
(P Z 0.02); I2 Z 54%
Tau2 Z 0.04;
Chi2 Z 5.28, df Z 5
(P Z 0.38); I2 Z 5%
Tau2 Z 0.81;
Chi2 Z 15.49, df Z 5
(P Z 0.008); I2 Z 68%
Test for overall effect: Z Z 9.20 (P < 0.00001) Z Z 8.96 (P < 0.00001) Z Z 5.69 (P < 0.00001)
a Inclusion criteria: Meta-analysis included all neurologically symptomatic or asymptomatic patients with unilateral or bilateral
70e99% stenoses and/or unilateral or bilateral carotid occlusions who underwent their cardiac surgery procedure without prophylactic
CEA or CAS.
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neurologically asymptomatic patients (up to 97% in the
USA128) and the majority have unilateral carotid disease.
Accordingly, in order to establish whether asymptomatic
carotid stenoses were associated with an increased risk of
stroke after cardiac surgery, it was necessary to exclude
outcome data from; (i) neurologically symptomatic patients
(i.e. those who reported any prior history of TIA or stroke)
and (ii) neurologically asymptomatic patients with an iso-
lated carotid occlusion or bilateral carotid occlusions (who
could never benefit from prophylactic CEA/CAS), whilst
retaining patients with an occlusion contralateral to
a significant (but operable) carotid stenosis.
Table 4 details the 30-day risks of death, stroke and
death/stroke in 13 natural history studies reporting
outcomes in 931 neurologically asymptomatic patientsTable 3 30-day rates of stroke, death and stroke/death after ca
patients who had ‘>80% stenosis’ (including occlusion) who did n
80e99% stenosis or occlusion
Author Year n Z Stroke
Schwartz28 1995 70 4 5
D’Agostino23 1996 71 7 9
Hines34 1998 15 4 2
Gott33 1999 37 6 1
Birincioglu31 1999 22 2 9
Gaudino24 2001 73 1 1
Schoof40 2007 200 7 3
Combined estimate (95%CI): 9.1% (4.8%e16%)
Heterogeneity: Tau2 Z 0.55; Ch
Test for overall effect: Z Z 6.77 (P < 0.
a Inclusion criteria: meta-analysis included all neurologically sym
80e99% stenoses and/or unilateral or bilateral carotid occlusions who
CEA or CAS.undergoing isolated cardiac surgery in the presence of an
untreated 50e99% stenosis. In this analysis, a ’50e99%
stenosis’ included patients with a unilateral 50e99%
stenosis, bilateral 50e99% stenoses or a 50e99% stenosis
with contralateral occlusion. Using this method of analysis,
the 30-day risk of stroke was now only 3.8% (95%CI
2.0e7.4), mortality was 3.8% (95%CI 2.0e4.8), while the
prevalence of peri-operative death/stroke was 3.8% (95%CI
2.0e6.5).
However, Table 4 only details outcomes for asymptom-
atic patients with 50e99% stenoses. Does the risk of stroke
increase in neurologically asymptomatic patients with more
severe carotid disease? Table 5 provides outcome data in
neurologically asymptomatic patients undergoing an iso-
lated cardiac surgery procedure in the presence of
a 70e99% stenosis (defined as the presence of a unilateralrdiac surgery in neurologically symptomatic or asymptomatic
ot undergo prophylactic CEA/CAS.a
Death Death/stroke
.7%
.9%
6.7% 1 6.7% 4 26.7%
6.2%
.1%
.4% 1 1.4% 2 2.8%
.5%
i2 Z 19.83, df Z 6 (P Z 0.003); I2 Z 70%
00001)
ptomatic or asymptomatic patients with unilateral or bilateral
underwent their cardiac surgery procedure without prophylactic
Table 4 30-day death, stroke and stroke/death in neurologically asymptomatic patients undergoing cardiac surgery with
50e99% carotid stenoses and who did not undergo prophylactic CEA or CAS.a
Author Year n Z Death Any CVA Death or any CVA
Ivey29 1984 16 0 0.0% 0 0.0% 0 0.0%
Brener22 1987 64 10 15.6% 4 6.2% 13 20.0%
Schultz27 1988 50 0 0.0% 0 0.0% 0 0.0%
Schwartz28 1995 117 e 4 3.4%
D’Agostino23 1996 182 e 7 3.8%
Mickelborough26 1996 16 0 0.0% 1 6.2% 1 6.2%
Ali21 1998 46 0 0.0% 0 0.0% 0 0.0%
Safa19 1999 94 0 0.0% 1 1.1% 1 1.1%
Gaudino24 2001 73 1 1.4% 1 1.4% 2 2.8%
Ghosh17 2005 50 2 4.0% 0 0.0% 2 4.0%
Manabe25 2008 42 0 0.0% 0 0.0% 0 0.0%
Li18 2009 120 e 2 1.7%
Baiou16 2009 61 3 4.9% 0 0.0% 3 4.9%
Combined estimate (95%CI): 3.8% (2%e7.4%) 3.8% (2%e4.8%) 3.8% (2%e6.5%)
Heterogeneity: Tau2 Z 0.85;
Chi2 Z 20.66, df Z 9
(P Z 0.01); I2 Z 56%
Tau2 Z 0.00;
Chi2 Z 10.00, df Z 12
(P Z 0.62); I2 Z 0%
Tau2 Z 0.00;
Chi2 Z 5.60, df Z 8
(P Z 0.69); I2 Z 0%
Test for overall effect: Z Z 7.72 (P < 0.00001) Z Z 16.87 (P < 0.00001) Z Z 11.74 (P < 0.00001)
a All patients were neurologically asymptomatic and had either a unilateral 50e99% stenosis (excluding occlusion), bilateral 50e99%
stenoses (excluding occlusion) or a unilateral 50e99% stenosis with a contralateral occlusion.
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eral 70e99% stenosis þ contralateral occlusion). Cardiac
surgery patients with untreated asymptomatic 70e99%
carotid stenoses incurred a 30-day stroke risk of only 2.0%
(95%CI 1.0e5.7), a mortality rate of 4.8% (95%CI 2.0e9.1)
and a death/stroke rate of 4.8% (95%CI 2.9e9.1).
The next meta-analysis sought to determine whether
peri-operative strokes rates were different in patients with
bilateral as opposed to unilateral asymptomatic carotid
disease. Table 6 details the 30-day risks of (i) death, (ii)
ipsilateral stroke, (iii) any stroke, (iv) death/ipsilateral
stroke and (v) death/any stroke in 621 neurologically
asymptomatic patients with a unilateral 50e99% stenosis
who underwent their cardiac surgery procedure without
staged or synchronous CEA/CAS. The 30-day mortality rate
was 4.8% (95%CI 2.0e10.7), the rate of ipsilateral stroke
was only 2.0% (95%CI 1.0e3.8%), the rate of ‘any’ stroke
was 2.9% (95%CI 2.0e5.7), the rate of death/ipsilateralTable 5 30-day death, stroke and stroke/death in neurologic
70e99% stenoses and who did not undergo prophylactic CEA or C
Author Year n Z Death
Mickelborough26 1996 16 0 0.0%
Safa19 1999 94 0 0.0%
Ghosh17 2005 50 2 4.0%
Li18 2009 51
Baiou16 2009 61 3 4.9%
Combined estimate (95%CI): 4.8% (2%e9.1%)
Heterogeneity: Tau2 Z 0.00;
Chi2 Z 2.67, df Z 3
(P Z 0.45); I2 Z 0%
Test for overall effect: Z Z 8.00 (P < 0.0000
a All patients were neurologically asymptomatic and had either a u
stenoses (excluding occlusion) or a unilateral 70e99% stenosis with cstroke was 3.8% (95%CI 2.0e7.4%), while the 30-day rate of
death/any stroke was 5.7% (95%CI 2.0e13.0%).
In order to address the question whether asymptomatic
patients with more severe, unilateral stenoses faced
a higher risk of stroke after cardiac surgery than patients
with unilateral 50e99% stenoses, Table 7 details the 30-day
prevalence of; (i) death, (ii) ipsilateral stroke, (iii) any
stroke, (iv) death/ipsilateral stroke and (v) death/any
stroke in neurologically asymptomatic patients with
a unilateral 70e99% stenosis, while Table 8 provides similar
outcome data for patients with a unilateral 80e99%
stenosis.
Due to the relatively small numbers (and large number
of ‘zeros’), it was not possible to perform a statistically
meaningful meta-analysis. However, the data from Tables 7
and 8 suggest that the risks of ipsilateral and ‘any’ stroke
remained very low and did not increase with stenosis
severity.ally asymptomatic patients undergoing cardiac surgery with
AS.a
Any CVA Death or any CVA
1 6.2% 1 6.2%
1 1.1% 1 1.1%
0 0.0% 2 4.0%
0 0.0%
0 0.0% 3 4.9%
2% (1%e5.7%) 4.8% (2.9%e9.1%)
Tau2 Z 0.08;
Chi2 Z 4.27, df Z 4
(P Z 0.37); I2 Z 6%
Tau2 Z 0.00;
Chi2 Z 2.61, df Z 3
(P Z 0.46); I2 Z 0%
1) Z Z 7.52 (P < 0.00001) Z Z 8.78 (P < 0.00001)
nilateral 70e99% stenosis (excluding occlusion), bilateral 70e99%
ontralateral occlusion.
Table 6 Prevalence of stroke in neurologically asymptomatic patients with a unilateral 50e99% carotid stenosis (excluding occlusion) undergoing isolated cardiac surgery.a
Name Year n Z Death Ipsilateral stroke Any stroke Death/ipsilateral stroke Death/any stroke
Ivey 198429 13 0 0.0% 0 0.0% 0 0.0% 0 0.0% 0 0.0%
Furlan 198530 18 0 0.0% 0 0.0%
Brener 198722 49 9 18.0% 2 3.7% 3 6.1% 11 22.0%
Schwartz 199528 67 1 1.5% 1 1.5%
Mickelborough 199626 15 0 0.0% 0 0.0% 1 6.6% 1 6.6% 1 6.6%
D’Agostino 199623 137 0 0.0% 4 2.9%
Ali 199821 13 0 0.0% 0 0.0% 0 0.0% 0 0.0% 0 0.0%
Safa 199919 71 0 0.0% 0 0.0% 1 1.4% 1 1.4% 1 1.4%
Gaudino 200124 73 1 1.4% 0 0.0% 1 1.4% 1 1.4% 2 2.7%
Ghosh 200517 20 0 0.0% 0 0.0%
Manabe 200825 32 0 0.0% 0 0.0% 0 0.0% 0 0.0% 0 0.0%
Li 200918 51 0 0.0% 0 0.0%
Baiou 200916 61 3 4.9% 0 0.0% 0 0.0% 3 4.9% 3 4.9%
Combined estimate (95%CI): 4.8% (2%e10.7%) 2% (1%e3.8%) 2.9% (2%e5.7%) 3.8% (2%e7.4%) 5.7% (2%e13%)
Heterogeneity: Tau2 Z 0.99;
Chi2 Z 16.83, df Z 7
(P Z 0.02); I2 Z 58%
Tau2 Z 0.00;
Chi2 Z 6.00, df Z 12
(P Z 0.92); I2 Z 0%
Tau2 Z 0.00;
Chi2 Z 6.86, df Z 12
(P Z 0.87); I2 Z 0%
Tau2 Z 0.00;
Chi2 Z 3.44, df Z 6
(P Z 0.75); I2 Z 0%
Tau2 Z 0.98;
Chi2 Z 20.24, df Z 7
(P Z 0.005); I2 Z 65%
Test for overall effect: Z Z 6.13 (P < 0.00001) Z Z 11.66 (P < 0.00001) Z Z 13.83 (P < 0.00001) Z Z 9.63 (P < 0.00001) Z Z 6.03 (P < 0.00001)
a All patients had a unilateral 50e99% stenosis i.e. no patient had a unilateral occlusion, contralateral stenosis >50% or contralateral occlusion and no patient underwent prophylactic
CEA or CAS within 30 days of the cardiac procedure.
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Table 7 Prevalence of stroke in neurologically asymptomatic patients with a unilateral 70e99% carotid stenosis (excluding
occlusion) undergoing isolated cardiac surgery.a
Name Year n Z Death Ipsilateral stroke Any stroke Death/ipsilateral stroke Death/any stroke
Mickelborough26 1996 15 0 0.0% 0 0.0% 1 6.6% 1 6.6% 1 6.6%
Ali21 1998 13 0 0.0% 0 0.0% 0 0.0% 0 0.0% 0 0.0%
Safa19 1999 71 0 0.0% 0 0.0% 1 1.4% 1 1.4% 1 1.4%
Ghosh17 2005 20 0 0.0% 0 0.0%
Li18 2009 51 0 0.0% 0 0.0%
Baiou16 2009 61 3 4.9% 0 0.0% 0 0.0% 3 4.9% 3 4.9%
a All patients had a unilateral 70e99% stenosis i.e. no patient had a unilateral occlusion, contralateral stenosis >70% or contralateral
occlusion and no patient underwent prophylactic CEA or CAS within 30 days of the cardiac procedure.
614 A.R. Naylor, M.J. BownThe next question was whether neurologically asymp-
tomatic patients with bilateral carotid disease faced
a higher risk of stroke following isolated cardiac surgery
than patients with unilateral disease. This was addressed in
Table 9, which details outcomes in 206 neurologically
asymptomatic patients with bilateral 50e99% stenoses or
a 50e99% stenosis plus contralateral occlusion who did not
undergo prophylactic CEA/CAS. A meta-analysis showed
that the mortality rate was 6.5% (95%CI 2.9e17.4%), the
prevalence of ‘any’ stroke was 6.5% (95%CI 3.5e11.5%),
while the 30-day risk of death/stroke was 9.1% (95%CI
3.8e20.6).
Outcomes from the constituent studies in Table 9 were
then stratified for stenosis severity (70e99% versus
80e99%) to see if the risk of peri-operative stroke
increased with the severity of the bilateral carotid disease
(Table 10). Once again, the numbers were too small to
permit meaningful meta-analyses to be undertaken, but
there was no systematic evidence that patients with
bilateral 80e99% stenoses (or an 80e99% stenosis plus
a contralateral occlusion) incurred significantly higher
risks of peri-operative stroke than patients with bilateral
50e99% stenoses.
In summary; compared with the rates of stroke identi-
fied in the first systematic review, patients with asymp-
tomatic carotid disease (excluding isolated or bilateral
occlusion) who underwent cardiac surgery without
prophylactic CEA/CAS incurred much lower stroke risks.
The risk of any stroke was lowest in patients with unilateral
asymptomatic carotid stenoses (3%) and was highest in
neurologically asymptomatic patients with bilateral carotid
disease (6%). There was no evidence that patients with
unilateral 70e99% or 80e99% stenoses incurred a higher riskTable 8 Prevalence of stroke in neurologically asymptomatic p
occlusion) undergoing isolated cardiac surgery.a
Name Year n Z Death Ipsilateral stroke Any
Schwartz28 1995 35 1 2.9% 1
Ali21 1998 8 0 0.0% 0 0.0% 0
Gaudino24 2001 73 1 1.4% 0 0.0% 1
Ghosh17 2005 5 0 0.0% 0
Manabe25 2008 6 0 0.0% 0 0.0% 0
Li18 2009 16 0 0.0% 0
a All patients had a unilateral 80e99% stenosis i.e. no patient had a
occlusion and no patient underwent prophylactic CEA or CAS within 3of stroke than patients with unilateral 50e99% stenoses.
The evidence would also suggest that the published risk of
stroke has reduced over the last two decades and especially
since about 1998 (Tables 6e10).Systematic review number #3
What was the prevalence of stroke in the hemisphere
ipsilateral to a non-operated asymptomatic severe
stenosis (or occlusion) in patients with severe bilateral
carotid disease undergoing a synchronous unilateral
CEA D cardiac procedure?
If severe carotid disease really was an important cause of
stroke after cardiac surgery, one would expect that
patients with severe, bilateral carotid disease undergoing
a unilateral synchronous CEA plus cardiac surgery proce-
dure would incur a higher rate of stroke in the hemisphere
ipsilateral to the non-operated (contralateral) stenosis or
occlusion. This was the subject of the third review.
Thirty-five studies reported outcomes in 954 patients
with bilateral 50e99% stenoses and 1295 patients with
bilateral 50e99% stenoses or a 50e99% stenosis plus
contralateral occlusion, who then underwent a unilateral
synchronous CEA þ cardiac surgery procedure (Table 11). In
virtually every case, the non-operated severely stenosed or
occluded contralateral carotid artery was neurologically
asymptomatic. A meta-analysis indicated that the 30-day
risk of stroke in the hemisphere ipsilateral to a non-oper-
ated (contralateral) 50e99% stenosis was 3.8% (95%CI
2.0e4.8). The prevalence of stroke in the hemisphere
ipsilateral to a non-operated (contralateral) 50e99%
stenosis or occlusion was also 3.8% (95% CI 2.9e4.8).atients with a unilateral 80e99% carotid stenosis (excluding
stroke Death/ipsilateral stroke Death/any stroke
2.9%
0.0% 0 0.0% 0 0.0%
1.4% 1 1.4% 2 2.7%
0.0%
0.0% 0 0.0% 0 0.0%
0.0%
unilateral occlusion, contralateral stenosis >80% or contralateral
0 days of the cardiac procedure.
Table 9 Prevalence of stroke in neurologically asymptomatic patients with bilateral 50e99% carotid stenoses or a 50e99%
stenosis þ contralateral occlusion undergoing isolated cardiac surgery.a
Name Year n Z Death Any stroke Death or any stroke
Ivey29 1984 3 0 0.0% 0 0.0% 0 0.0%
Furlan30 1985 11 1 9.1%
Brener22 1987 15 1 6.7% 1 6.7% 2 13.0%
Schwartz28 1995 50 1 2.0%
Mickelborough26 1996 1 0 0.0% 0 0.0% 0 0.0%
D’Agostino23 1996 45 3 6.7%
Ali21 1998 18 0 0.0% 0 0.0% 0 0.0%
Safa19 1999 23 0 0.0% 0 0.0% 0 0.0%
Ghosh17 2005 30 0 0.0%
Manabe25 2008 10 0 0.0% 0 0.0% 0 0.0%
Combined estimate (95%CI): 6.5% (2.9%e17.4%) 6.5% (3.8%e11.5%) 9.1% (3.8%e20.6%)
Heterogeneity: Tau2 Z 0.00;
Chi2 Z 2.54, df Z 5
(P Z 0.77); I2 Z 0%
Tau2 Z 0.00;
Chi2 Z 5.35, df Z 9
(P Z 0.80); I2 Z 0%
Tau2 Z 0.00;
Chi2 Z 3.66, df Z 5
(P Z 0.60); I2 Z 0%
Test for overall effect: Z Z 4.96 (P < 0.00001) Z Z 8.55 (P < 0.00001) Z Z 4.74 (P < 0.00001)
a All patients were neurologically asymptomatic, none underwent CEA or CAS within 30 days of the cardiac procedure and all had
either bilateral 50e99% stenoses or a 50e99% stenosis with contralateral occlusion.
Stroke after Cardiac Surgery and Asymptomatic Carotid Disease 615Nineteen studies reported outcomes in 349 patients with
bilateral 70e99% stenoses and 463 patients with bilateral
70e99% stenoses or a 70e99% stenosis plus a contralateral
occlusion, who then underwent a unilateral synchronous
CEA þ cardiac surgery procedure (Table 12). The preva-
lence of stroke in the hemisphere ipsilateral to a non-
operated contralateral 70e99% stenosis was 3.8% (95%CI
2.0e6.5). The prevalence of stroke in the hemisphere
ipsilateral to a non-operated, contralateral 70e99%
stenosis or occlusion was 3.8% (95%CI 2.0e6.5).
Finally, eight studies reported outcomes in 224 patients
with bilateral 80e99% stenoses and 349 patients with
bilateral 80e99% stenoses or an 80e99% stenosis plus
a contralateral occlusion, who then underwent a unilateral,
synchronous CEA þ cardiac surgery procedure (Table 13).
The prevalence of stroke ipsilateral to a non-operated
contralateral 80e99% stenosis was 5.7% (95%CI 2.9e11.5),
while the prevalence of stroke ipsilateral to a non-oper-
ated, contralateral 80e99% stenosis or occlusion was 3.8%
(95%CI 2.0e7.4).Table 10 Prevalence of stroke and death in neurologically asy
a severe stenosis and contralateral occlusion undergoing isolated
Name Year n Z Death
Bilateral 70e99% stenoses or 70e99% stenosis þ contralateral occ
Mickelborough26 1996 1 0 0.0
Ali21 1998 18 0 0.0
Safa19 1999 23 0 0.0
Ghosh17 2005 30
Bilateral 80e99% stenoses or 80e99% stenosis þ contralateral occ
Schwartz28 1995 19
Ali21 1998 11 0 0.0
Ghosh17 2005 25
Manabe25 2008 2 0 0.0
a No patient underwent prophylactic CEA or CAS within 30 days of tIn summary; the prevalence of stroke in the hemisphere
ipsilateral to a non-operated asymptomatic severe stenosis
(or occlusion) in patients with severe bilateral carotid
disease undergoing a synchronous unilateral CEA þ cardiac
procedure was relatively low (4%). The risk of stroke
increased to 5.7% in patients with bilateral 80e99%
stenoses undergoing a unilateral carotid/cardiac
procedure.Discussion
The management of patients with concurrent cardiac and
carotid disease remains enduringly controversial. Stroke is
undoubtedly an important cause of death and persisting
neurological disability after cardiac surgery, with a 2%
prevalence in systematic reviews1 and a number of strate-
gies have evolved to prevent this complication. One such
strategy is prophylactic CEA or CAS; the rationale being that
carotid disease is an important cause of peri-operativemptomatic patients with bilateral severe carotid stenoses or
cardiac surgery.a
Any stroke Death or any stroke
lusion
% 0 0.0% 0 0.0%
% 0 0.0% 0 0.0%
% 0 0.0% 0 0.0%
0 0.0%
lusion
1 5.3%
% 0 0.0% 0 0.0%
0 0.0% -
% 0 0.0% 0 0.0%
he cardiac procedure.
Table 11 Prevalence of stroke in the hemisphere ipsilateral to a contralateral, non-operated 50e99% stenosis or occlusion
following a synchronous unilateral CEA þ cardiac surgery in patients with bilateral significant carotid disease.
Stroke rate ipsilateral to a contralateral, non-operated ICA stenosis
50e99% 50e99% or occlusion
Naylor20 1/75 1.3% 1/101 1.0%
Ali21 0/27 0.0% 0/27 0.0%
Brener22 0/15 0.0% 2/22 9.1%
Furlan30,b, Hertzer53,a 2/69 2.9% 3/115 2.6%
Berens37 1/27 3.7% 1/32 3.1%
Bonardelli46 0/30 0.0% 0/34 0.0%
Bulat47 0/26 0.0% 0/33 0.0%
Carrel48 0/8 0.0% 0/13 0.0%
Dunn49 0/30 0.0% 0/30 0.0%
Estes50 2/89 2.2% 4/123 3.3%
Evagelopoulos51 0/127 0.0% 0/151 0.0%
Farooq52 0/5 0.0% 0/11 0.0%
Halpin54 0/10 0.0% 0/19 0.0%
Hertzer55,a 2/30 6.7% 3/48 6.2%
Horst56 0/34 0.0% 0/40 0.0%
Inciura57 0/22 0.0% 0/25 0.0%
Jahangiri57 0/9 0.0% 0/15 0.0%
Jauserran59 0/6 0.0% 0/8 0.0%
Kolh60 2/45 4.4% 4/62 6.5%
Kouchokos61 0/26 0.0% 0/50 0.0%
Kougias62 0/55 0.0% 1/77 1.3%
Lubicz63 0/10 0.0% 0/14 0.0%
Madi-Jebara64 0/7 0.0% 0/9 0.0%
Nwakanma65 0/12 0.0% 1/14 7.1%
O’Donnell66 0/7 0.0% 0/11 0.0%
Pome68 0/17 0.0% 0/23 0.0%
Rizzo69 0/55 0.0% 2/75 2.7%
Saccani70 0/7 0.0% 0/10 0.0%
Terraman71 0/11 0.0% 0/15 0.0%
Trachiotis72 0/15 0.0% 0/29 0.0%
Vicarett73 0/8 0.0% 0/9 0.0%
Vitali74 0/19 0.0% 0/26 0.0%
Weiss75 0/13 0.0% 0/15 0.0%
Youssuf76 0/8 0.0% 0/9 0.0%
Combined estimate (95%CI): 3.8% (2%e4.8%) 3.8% (2.9%e4.8%)
Heterogeneity: Tau2 Z 0.00; Chi2 Z 11.17,
df Z 33 (P Z 1.00); I2 Z 0%
Tau2 Z 0.00; Chi2 Z 17.75,
df Z 33 (P Z 0.99); I2 Z 0%
Test for overall effect: Z Z 16.89 (P < 0.00001) Z Z 19.75 (P < 0.00001)
a The two Hertzer series53,55 had a three year overlap (1969e76, vs 1973e81) so there may be a small number of duplicated patients.
b Furlan’s series30 contained 115 patients whose outcomes had also been reported in Hertzer’s series.53
616 A.R. Naylor, M.J. Bownstroke and that staged/synchronous CEA/CAS can be per-
formed with low enough complication rates to confer
benefit to the patient. The evidence supporting this prac-
tice has been serially updated by regulatory authorities and
the AHA suggest that performing a unilateral CEA þ cardiac
surgery procedure is ‘acceptable’ in patients with a 60e99%
asymptomatic carotid stenosis, provided the patient has
a life expectancy of >5 years and that CEA can be per-
formed in asymptomatic patients in the surgeon’s routine
practice with a death/stroke rate of 3%.4 The AHA
downgrades their recommendation to ‘uncertain’ should
the procedural risk increase to 3e5%, whilst retaining the
‘uncertain’ classification should the procedural risk
increase to 5e10%.4So why, given the AHA guidelines, is there still any
debate? The simple answer is that there is growing unease
amongst observers that the available evidence does not
support the hypothesis that asymptomatic carotid disease is
an important cause of stroke after cardiac surgery. If true,
this will invalidate any role for prophylactic CEA/CAS in
cardiac surgery patients, irrespective of how safely either
procedure can be performed.
A number of studies and systematic reviews have
previously concluded that carotid disease is an important
cause of stroke after cardiac surgery6e15 and these were
integral in developing an evidence based strategy for rec-
ommending prophylactic CEA/CAS by the AHA. However, in
retrospect, many of these studies were flawed because
Table 12 Prevalence of stroke in the hemisphere ipsilateral to a contralateral, non-operated 70e99% stenosis or occlusion
following a synchronous unilateral CEA þ cardiac surgery in patients with bilateral significant carotid disease.
Stroke rate ipsilateral to contralateral, non-operated ICA disease
70e99% 70e99% or occlusion
Madi-Jebara64 0/7 0.0% 0/9 0.0%
Saccani70 0/7 0.0% 0/10 0.0%
Youssuf76 0/8 0.0% 0/9 0.0%
Nwakanma65 0/12 0.0% 1/14 7.1%
Pome68 0/17 0.0% 0/23 0.0%
Vicarett73 0/8 0.0% 0/9 0.0%
Farooq52 0/5 0.0% 0/11 0.0%
Horst56 0/34 0.0% 0/40 0.0%
Naylor20 0/21 0.0% 0/35 0.0%
Kougias62 0/55 0.0% 1/77 1.3%
Dunn49 0/30 0.0% 0/30 0.0%
Bulat47 0/26 0.0% 0/33 0.0%
Jauserran59 0/6 0.0% 0/8 0.0%
Carrel48 0/8 0.0% 0/13 0.0%
Jahangiri57 0/9 0.0% 0/15 0.0%
Inciura57 0/22 0.0% 0/25 0.0%
Kolh60 2/45 4.4% 4/62 6.5%
Lubicz63 0/10 0.0% 0/14 0.0%
Vitali74 0/19 0.0% 0/26 0.0%
Combined estimate (95%CI): 3.8% (2%e6.5%) 3.8% (2%e6.5%)
Heterogeneity: Tau2 Z 0.00; Chi2 Z 4.06,
df Z 18 (P Z 1.00); I2 Z 0%
Tau2 Z 0.00; Chi2 Z 6.97,
df Z 18 (P Z 0.99); I2 Z 0%
Test for overall effect: Z Z 10.74 (P < 0.00001) Z Z 12.23 (P < 0.00001)
Stroke after Cardiac Surgery and Asymptomatic Carotid Disease 617they combined outcomes for symptomatic and asymptom-
atic patients and also included isolated/bilateral occlusions
in order to artificially increase the risk of stroke associated
with cardiac surgery. Why is this important? Firstly,
systematic reviews have shown that patients reporting
a prior history of stroke or TIA face a threefold increased
risk of stroke following cardiac surgery, as compared to
those who are neurologically asymptomatic.1 No-one really
disputes that cardiac surgery patients with a prior history ofTable 13 Prevalence of stroke in the hemisphere ipsilateral to
following a synchronous unilateral CEA þ cardiac surgery in patie
Stroke rate ipsilateral to contralat
80e99%
Ali21 0/11 0.
Halpin54 0/10 0.
Naylor20 1/10 10
Estes50 1/34 2.
Berens37 1/11 9.
Trachiotis72 0/15 0.
Evagelopoulos51 0/127 0.
Kouchoukos61 0/6 0.
Combined estimate (95%CI): 5.7% (2.9%e11.5%)
Heterogeneity: Tau2 Z 0.00; Chi2 Z 6.32,
df Z 7 (P Z 0.50); I2 Z 0
Test for overall effect: Z Z 7.08 (P < 0.00001)stroke/TIA will benefit from staged or synchronous CEA or
CAS, but they do constitute only a very small minority of
patients being considered for prophylactic intervention.
Between 2000 and 2004, 27,084 patients underwent
concurrent cardiac and carotid revascularisation in the USA
and 97% were neurologically asymptomatic.128 The vast
majority of patients were, therefore, neurologically
asymptomatic with unilateral carotid disease. Secondly,
because isolated or bilateral occlusions (which cannot bea contralateral, non-operated 80e99% stenosis or occlusion
nts with bilateral significant carotid disease.
eral, non-operated ICA disease
80e99% or occlusion
0% 0/11 0.0%
0% 0/19 0.0%
.0% 1/36 2.8%
9% 3/68 4.4%
1% 1/16 6.2%
0% 0/29 0.0%
0% 0/151 0.0%
0% 0/19 0.0%
3.8% (2%e7.4%)
%
Tau2 Z 0.00; Chi2 Z 5.01,
df Z 7 (P Z 0.66); I2 Z 0%
Z Z 9.36 (P < 0.00001)
618 A.R. Naylor, M.J. Bowntreated by either CEA or CAS) are associated with much
higher rates of peri-operative stroke after isolated cardiac
surgery (up to 11% in some systematic reviews1), their
inclusion will artificially increase the ‘natural history’ risk
of stroke and overestimate any benefit likely to accrue to
asymptomatic patients with operable lesions. It is, there-
fore, totally inappropriate to develop management strate-
gies for application in predominantly asymptomatic
patients which are based on data derived from studies
including higher risk symptomatic patients and those with
carotid occlusion.
The importance of excluding symptomatic patients and
those with isolated or bilateral occlusions was clearly
apparent when comparing the stroke rates observed in
Tables 1e3 (systematic review #1) with those observed in
Tables 4e5 (systematic review #2). Note that when cardiac
surgery patients with carotid disease were combined (as
was typical in historical systematic reviews), the peri-
operative stroke rate was 7.4% for patients with ‘>50%’ or
‘>70%’ lesions, increasing to 9.1% in patients with ‘>80%’
disease (i.e. quite considerable). However, when symp-
tomatic patients and those with isolated or bilateral
occlusions were excluded (Tables 4e5), the risk of ‘any’
stroke following isolated cardiac surgery in neurologically
asymptomatic patients fell to 3.8% (50e99% stenoses) and
2.0% (70e99% stenoses). This is a complete order of
magnitude lower than is currently being used to justify
intervening in neurologically asymptomatic patients
undergoing cardiac surgery.
The second systematic review then separated outcomes
for patients with unilateral and bilateral asymptomatic
disease and suggested that the prevalence of ipsilateral
stroke (2.0%) and any stroke (2.9%) was extremely low in
patients with a 50e99% unilateral carotid stenosis. In addi-
tion, there was no evidence that the risk of stroke increased
in patients with a unilateral 70e99% or a unilateral 80e99%
stenosis (Tables 7 and 8). Accordingly, at these low levels of
risk, it is hard to see how prophylactic CEA or CAS could ever
confer meaningful benefit to the patient, even if the proce-
dures were performed with zero percent risk.
Critics might argue that the quality of data in the
constituent trials in the second systematic review were
rather poor (we would agree). However, Tables 6e8
represent all of the natural history data for patients with
unilateral, asymptomatic carotid stenoses that are
currently available to regulatory bodies (such as the AHA)
to formulate ‘evidence’ based recommendations for prac-
tice. It has been suggested that patients with severe
carotid stenoses (including those with unilateral disease)
may have areas of haemodynamically compromised brain
that makes them more vulnerable to embolisation from the
aortic arch and that treating these carotid stenoses will
reduce the risk of stroke.173 However, while this hypothesis
may at first seem attractive, one would still have expected
to have observed an increased risk of ipsilateral stroke in
the published natural history studies where no prophylactic
carotid revascularisation had taken place. As can be seen
from Tables 6e8, this was not the case.
The meta-analysis in Table 9 does, however, suggest that
the risk of stroke may be higher in patients with bilateral
asymptomatic disease (6.5%). This will be discussed later
(in association with the third systematic review), but it isworth bearing in mind that the proportion of patients with
bilateral, severe carotid disease undergoing cardiac surgery
is extremely low. In an earlier systematic review analysing
the prevalence of significant carotid disease in ultrasound
screened patients prior to cardiac surgery, only 2.2% of
patients were found to have bilateral 50e99% stenoses
(another 0.5% had a 50e99% stenosis þ contralateral
occlusion), whilst only 1% were found to have bilateral
80e99% stenoses on pre-operative screening.1 These data,
therefore, suggest that even if prophylactic CEA/CAS was
still considered appropriate in neurologically asymptomatic
patients with severe bilateral disease, only 1e2% of cardiac
surgery patients would benefit from prophylactic carotid
revascularisation.
The lack of any clear association between asymptomatic
carotid disease and stroke after cardiac surgery has led an
increasing number of observers to conclude that there are
other more important causes of stroke after cardiac
surgery. In 1998, Barbut observed that almost 80% of stroke
sufferers after cardiac surgery had multiple areas of
infarction in either the vertebrobasilar territory or in both
cerebral hemispheres, indicating that carotid disease
(alone) could not have been responsible.174 In a systematic
review of the literature in 2002, Naylor examined stroke
rates in 4674 cardiac surgery patients who had been
screened pre-operatively for carotid disease and observed
that 82/96 (86%) of strokes could not have been attribut-
able to significant carotid disease.1 Similarly, Schoof
reported patterns of carotid disease in 67 patients who
suffered a stroke following cardiac surgery and observed
that 94% did not have a significant carotid stenosis,40 while
Stamou observed that in a cohort of 333 patients suffering
a stroke after 16,528 cardiac surgery procedures, 94% could
not be attributed to carotid disease.175 More recently, Li et
al. have shown that 95% of strokes that occurred after
cardiac surgery could not be attributable to carotid disease
and then speculated about whether the remaining 5% of
strokes could have been prevented by prophylactic CEA/
CAS.18 Li identified 76 patients (out of a cohort of 4335
cardiac surgery patients) who suffered a post-operative
stroke. Of these, 72 (95%) could not have been caused by
carotid disease. More importantly, out of the four whose
strokes might have been attributable to carotid disease,
none could have benefited from prophylactic CEA or CAS
(unilateral asymptomatic 60% stenosis (n Z 1), known
occlusion (n Z 3). These findings, together with the meta-
analyses conducted in the second systematic review, cast
considerable doubt on the hypothesis that asymptomatic
carotid disease (especially unilateral disease) is a major
cause of stroke following cardiac surgery.
However, would it still be reasonable to offer prophy-
lactic CEA/CAS to neurologically asymptomatic patients
with bilateral severe carotid disease? The second system-
atic review found that the risk of stroke did increase in
patients with bilateral severe carotid disease. The third
systematic review then examined the published data in
a different manner, following the publication of a study
which showed that there seemed to be a very low risk of
stroke in the territory of a non-operated, contralateral
carotid artery in patients with severe bilateral disease
undergoing a unilateral synchronous carotid/cardiac
procedure.20 In this series, 132 patients underwent
Stroke after Cardiac Surgery and Asymptomatic Carotid Disease 619a unilateral synchronous procedure by the same surgeon
and 101 (76%) were undertaken in the presence of an
unoperated, contralateral 50e99% stenosis or occlusion; 80
(45%) had a contralateral, non-operated 60e100% stenosis
or occlusion, while 80 (52%) had an unoperated, contra-
lateral 70e99% stenosis or occlusion. Only one of these
patients suffered a stroke in the hemisphere ipsilateral to
a non-operated stenosis (90% asymptomatic stenosis pre-
operatively) following a unilateral synchronous car-
diac þ carotid procedure.20
This seemed to be a very important observation, as it
was completely counter-intuitive to what one might have
expected if carotid disease was an important cause of
stroke during cardiac surgery. Tables 11e13 detail the
results of three meta-analyses of stroke rates (following
stratification for increasing stenosis severity). As can be
seen, the stroke rate in the hemisphere ipsilateral to a non-
operated contralateral stenosis or occlusion in patients
with bilateral severe carotid disease undergoing a unilat-
eral synchronous CEA þ cardiac procedure was 3.8%
(50e100% or 70e100%). The stroke risk did, however,
increase to 5.7% in patients with 80e100% stenoses/occlu-
sions, though this may, in part, be a consequence of the
statistical method adopted for analysing this type of data
because of problems dealing with studies reporting zero
percent risks.Implications for practice?
These systematic reviews have highlighted important
anomalies that challenge the hypothesis that asymptomatic
carotid disease (especially unilateral stenoses) is an
important cause of stroke after cardiac surgery. It is,
however, an indisputable fact that the risk of stroke
increases in cardiac surgery patients who have concurrent
carotid disease but, to paraphrase Michael Borger; this may
simply mean that carotid disease is no more than a surro-
gate for severe atherosclerotic disease in the aortic arch,5
and many now consider this pathology to be the single most
important cause of stroke after cardiac surgery.5
So how might these new data influence clinical practice?
Although not the subject of this paper, few would challenge
the appropriateness of undertaking staged or synchronous
CEA/CAS in neurologically symptomatic patients under-
going cardiac surgery. Patients with bilateral, severe
asymptomatic carotid disease probably do face a slightly
increased risk of stroke and, while the quality of data are
relatively poor, it would still seem reasonable to consider
prophylactic CEA/CAS in this very small subgroup of
patients (1e2% of all cardiac surgery patients). This is
clearly an area where much better natural history data are
required.
However, the main finding from this series of systematic
reviews is that it is now extremely questionable whether
prophylactic CEA/CAS can be recommended in neurologi-
cally asymptomatic patients with unilateral carotid
disease. Given that the vast majority of patients currently
undergoing concurrent carotid/cardiac revascularisation
have unilateral asymptomatic carotid disease and incur
9e10% risks of death/stroke following staged or synchro-
nous CEA/CAS,176,177 this does seem to be rather a highprice to pay if unilateral asymptomatic carotid disease is
not a major cause of stroke after cardiac surgery. It is now
time for a radical review of guidelines which uncritically
recommend performing CEA or CAS in neurologically
asymptomatic patients with unilateral carotid stenoses.
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